Effectiveness of Low-Dose Doxycycline in Sjögren's Syndrome
Author Information
Author(s): Hubertus Seitsalo, Raija K Niemelä, Magdalena Marinescu-Gava, Tuija Vuotila, Leo Tjäderhane, Tuula Salo
Primary Institution: University of Oulu
Hypothesis
Low-dose doxycycline could be effective in treating Sjögren's syndrome by decreasing tissue damage and subjective symptoms.
Conclusion
Low-dose doxycycline may not be useful in reducing the primary symptoms of Sjögren's syndrome.
Supporting Evidence
- The study involved 22 patients who were randomly assigned to receive either the medication or placebo.
- Seventeen out of 22 patients completed the study and provided data.
- Statistically significant increases in fatigue were observed with low-dose doxycycline.
Takeaway
The study tested a medicine called low-dose doxycycline to see if it helps people with a condition called Sjögren's syndrome, but it didn't really make a difference.
Methodology
This was a randomized, double-blind, placebo-controlled cross-over study involving 22 patients who received either low-dose doxycycline or placebo for 10 weeks.
Potential Biases
The study was double-blind, reducing bias risks, but the small sample size may limit the reliability of the findings.
Limitations
The study had a small sample size and the subjective symptoms may reflect normal fluctuations rather than true medication effects.
Participant Demographics
All participants were women with primary Sjögren's syndrome.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website